Clearing Up Misperceptions About the Pain Standards

Published Online: Friday, November 1, 2013
Follow Pharmacy_Times:
In this podcast, Pat Adamski, director of the Joint Commission's Standards Interpretations Group, clears up common misperceptions about the organization's pain standards.

To listen to the podcast, click here.
Related Articles
The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.
Chronic pain patients using prescription opioids in conjunction with medical marijuana are not at increased risk for substance abuse.
Regular trips to the emergency department could be a red flag for deadly prescription drug overdose.
$vacMongoViewPlus$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$